+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Vascular Health Supplements Market by Form (Capsule, Liquid, Powder), Ingredient Type (Coenzyme Q10, Hawthorn Extract, L-Arginine), Distribution Channel, Target Audience, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6122673
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Over the past decade, the global health community has witnessed a remarkable rise in awareness surrounding the maintenance of a healthy vascular system. Cardiovascular diseases remain a leading cause of mortality, prompting individuals and healthcare practitioners to seek preventive and supportive nutritional solutions. Within this evolving context, vascular health supplements have emerged as a pivotal category that blends traditional botanicals with cutting-edge nutraceutical science to promote arterial function and overall circulatory wellbeing.

Consumers are increasingly prioritizing proactive interventions that can mitigate the risk of endothelial dysfunction and arterial stiffness. Growth in digital health platforms has empowered individuals to access information on supplement efficacy, driving more informed decision making. At the same time, manufacturers are investing heavily in research to validate the mechanisms of action of ingredients such as Hawthorn extract and L-Arginine. This rigorous approach has fostered greater trust among healthcare professionals, reinforcing the role of high-quality supplements as a complementary strategy alongside lifestyle modifications.

As the industry deepens in complexity, stakeholders face the challenge of navigating intricate global supply chains, evolving regulatory frameworks, and a diverse array of formulation options. This executive summary delivers a comprehensive overview of the critical trends shaping the field, equipping investors, product developers, and marketers with the insights needed to craft compelling value propositions. Through detailed analysis, readers will gain clarity on segmentation dynamics, regional activity, and competitive positioning strategies that will define success in the coming years.

By bridging scientific rigor with strategic intelligence, this research aims to inform decisions that drive innovation and sustainable growth. Whether refining an existing product portfolio or evaluating new opportunities, executives and practitioners will discover evidence-based guidance to optimize their engagement with the vascular health supplement sector.

Uncovering the Major Paradigm Shifts Driving Cardiovascular Supplement Adoption Through Consumer Awareness Technological Innovation and Regulatory Evolution

The landscape of vascular health supplements has undergone a profound transformation driven by shifting consumer values and technological breakthroughs. Heightened awareness of cardiovascular wellbeing has pushed supplement makers to invest in clinically validated ingredients, while digital wellness platforms have accelerated knowledge sharing and product discovery. In parallel, advances in encapsulation and nanotechnology have improved bioavailability and shelf stability, enabling more effective formulations that resonate with discerning consumers.

From a regulatory standpoint, oversight bodies have strengthened labeling requirements and quality controls to ensure safety and transparency. These evolving standards have shifted the industry toward more collaborative relationships with research institutes and contract manufacturing organizations, creating a culture of accountability. This alignment between regulatory rigor and innovation has set a new benchmark for product development, compelling companies to invest in robust clinical trials and third-party certifications.

As the ecosystem continues to evolve, sustainability and traceability have risen to the forefront of buyer priorities. Brands that demonstrate ethical sourcing of Omega-3 fatty acids from responsibly managed fisheries or that leverage biodegradable packaging for capsules are gaining a competitive edge. Moving forward, the intersection of consumer education, technological innovation, and regulatory refinement will continue to redefine the opportunities and challenges facing the vascular health supplement sector.

Assessing the Cumulative Impact of New United States Tariffs on Vascular Health Supplements Supply Chains Pricing and Global Trade Dynamics in 2025

In response to escalating trade tensions and geopolitical realignments, the United States introduced a series of targeted tariffs on specialty supplement ingredients and finished preparations in early 2025. These duties have reverberated across global supply chains, elevating input costs for raw materials such as Coenzyme Q10 and Omega-3 fatty acids while creating volatility in freight and logistics expenses. Manufacturers reliant on cross-border sourcing have had to reassess procurement strategies, factoring in additional import duties and extended lead times.

Confronted with mounting cost pressures, many enterprises have pursued nearshoring initiatives to mitigate tariff exposure. This rebalancing of manufacturing footprints has fostered new partnerships in domestic food and pharmaceutical contract facilities, alleviating some of the logistical complexities but introducing fresh capacity constraints. At the same time, price adjustments at the retail level have tested consumer price elasticity, prompting brands to refine their value communication and loyalty programs as a means of sustaining engagement.

Looking beyond immediate cost implications, the 2025 tariff regime has sharpened industry focus on supply chain resilience and strategic inventory management. Forward-looking firms are diversifying their supplier networks, exploring alternative ingredient sources in Latin America and Southeast Asia, and negotiating long-term agreements to secure favorable pricing. As trade policies remain fluid, sustained adaptability and proactive risk mitigation will be essential to maintaining healthy margins and uninterrupted product availability across international markets.

InDepth Analysis of Form Ingredient Type Distribution Channel Target Audience and Application Insights Shaping the Vascular Health Supplement Industry

A nuanced understanding of consumer preferences across diverse formulation options is essential for identifying high-value opportunities in this sector. Supplement delivery vehicles span a range of forms including capsules, liquid concentrates, powders, softgels, and tablets, each offering distinct advantages in terms of absorption rates, convenience, and consumer acceptance. By aligning product form with consumption occasions-whether a morning routine or a preexercise regimen-brands can enhance adherence and differentiate from competitors.

Equally critical is the profiling of key ingredients. Coenzyme Q10 commands attention for its role in cellular energy production and antioxidant defense, while Hawthorn extract delivers time-honored cardiovascular support. L-Arginine has gained traction for its vasodilatory benefits, and Niacin continues to offer lipid modulation properties. Omega-3 fatty acids, renowned for their anti-inflammatory actions, round out a core ingredient set that addresses both preventive and therapeutic applications within the vascular health space.

Distribution channels reflect shifting consumer shopping behaviors. Health and specialty stores remain a mainstay for personalized service and in-store education, while online platforms, encompassing brand websites and third-party marketplaces, have accelerated convenience-driven purchases. Traditional pharmacy outlets, including both chains and independent retailers, leverage professional credibility to influence decision making, and supermarkets and hypermarkets offer the advantage of high foot traffic and crosscategory merchandising.

Understanding the demographic contours of the audience is pivotal as well. Adults over the age of 45 prioritize targeted cardiovascular interventions, while younger adults under 45 seek preventive strategies that support general wellbeing. Application segmentation distinguishes between preventive supplementation designed to maintain vascular health and therapeutic solutions aimed at addressing diagnosed concerns. Within preventive usage, emphasis on cardiovascular resilience and overall wellbeing informs messaging and product positioning across these segments.

Discovering Regional Dynamics and Growth Drivers Across Americas Europe Middle East Africa and AsiaPacific in Vascular Health Supplement Demand

Regional landscapes exhibit distinct drivers that influence the uptake of vascular health supplements. In the Americas, rising health care costs and an aging population have fueled demand for preventive interventions, prompting retailers to feature supplements alongside conventional therapies. Within North America, digital direct-to-consumer channels have become particularly influential, supporting subscriptionbased models and personalized supplement regimens.

Across Europe, the Middle East, and Africa, regulatory harmonization efforts under the European Union and heightened focus on stringent quality certifications have elevated consumer confidence. Local brands and multinational corporations alike navigate a patchwork of labeling standards and import regulations, spurring investment in compliance capabilities. In the Middle East, the adoption of wellness tourism has enhanced regional visibility for nutraceutical products, while African markets exhibit growing interest in plantderived ingredients that align with traditional herbal practices.

In the AsiaPacific region, shifting lifestyles and rising disposable incomes are expanding the footprint of vascular health supplements. In key markets such as China, Japan, and Australia, established health store networks coexist with rapidly growing e-commerce platforms. Consumer fascination with novel formulations and functional ingredients drives innovation, and crossborder collaborations facilitate knowledge exchange on clinical research and manufacturing best practices.

Examining Leading Industry Players Strategies Innovations and Competitive Positioning in the Vascular Health Supplement Market Landscape

Leading players in the vascular health supplement arena are distinguished by the depth of their R&D pipelines and their agility in responding to emerging consumer demands. Companies are forging partnerships with contract research organizations and academic institutions to validate the efficacy of proprietary blends, while investing in advanced encapsulation techniques to improve nutrient delivery and stability.

Strategic acquisitions and alliances have become central to expanding geographic reach and diversifying product portfolios. By integrating specialist ingredient suppliers, top firms are securing preferential access to highquality raw materials and enhancing their ability to innovate at pace. Concurrently, several organizations have established pilot manufacturing lines dedicated to smallbatch production, enabling rapid prototyping and market testing of novel formulations.

In a landscape where consumer trust is paramount, transparent communication of clinical outcomes and ingredient provenance has emerged as a differentiator. Leading brands deploy digital platforms to share peer-reviewed study summaries, interactive webinars, and expert interviews that deepen consumer engagement. This emphasis on educational content, coupled with valueadded services such as personalized wellness assessments, reinforces brand loyalty and positions companies as thought leaders within the vascular health ecosystem.

Strategic Recommendations for Industry Leaders to Capitalize on Emerging Trends Optimize Product Portfolios and Strengthen Market Position in Vascular Health Supplements

Industry leaders seeking to capitalize on the expanding appetite for vascular health supplements should consider a multifaceted strategy that integrates product innovation, regulatory collaboration, and digital engagement. First, investing in advanced formulation research enables the creation of differentiated offerings that harness synergistic ingredient combinations, optimized for bioavailability and targeted outcomes. By prioritizing clinical validation, brands can substantiate efficacy claims and build lasting credibility with health care professionals and consumers.

Engaging proactively with regulatory authorities and certification bodies further enhances product legitimacy and accelerates time to market. Establishing crossfunctional teams that include regulatory affairs experts, quality control specialists, and scientific liaisons ensures alignment with evolving standards and facilitates swift responses to compliance inquiries. Such an approach not only mitigates risk but also opens pathways to premium pricing tiers in regions where rigorous approvals command consumer trust.

On the digital front, cultivating an omnichannel presence is essential. Brands should integrate e-commerce storefronts with immersive educational content and personalized recommendation engines to guide purchase decisions. Social media activations featuring credible health experts can amplify brand narratives and foster community around vascular wellness. Additionally, building strategic alliances with telehealth providers and wellness platforms broadens distribution reach and embeds supplements within comprehensive health management programs.

Lastly, fortifying supply chain resilience through supplier diversification and scenario planning will safeguard production continuity. Organizations should leverage advanced analytics to monitor raw material availability and pricing trends, while forging longterm agreements with key ingredient producers to secure favorable terms. By weaving together these strategic imperatives, industry leaders will be positioned to thrive amid shifting consumer expectations and regulatory landscapes.

Comprehensive Research Methodology Integrating Primary Stakeholder Interviews Data Validation and Rigorous Secondary Data Analysis for Reliable Market Insights

This research is grounded in a robust methodological framework that combines primary stakeholder engagements with extensive secondary research. Senior executives, formulating scientists, and distribution channel experts were interviewed to capture nuanced perspectives on consumer behavior, regulatory developments, and supply chain dynamics. Through confidential oneonone discussions and structured surveys, the research team elicited forwardlooking insights and validated emerging trends.

Complementing these primary inputs, the report leverages a diverse array of secondary sources, including peerreviewed journals, industry publications, regulatory databases, and trade association reports. Data triangulation techniques were employed to ensure consistency across information streams, with discrepancies resolved through expert consultations. Quality assurance protocols encompassed standardization of terminology, crossreference of ingredient classification, and audit trails of data sources.

Segmentation analyses were performed to assess variations in form factors, ingredient types, distribution avenues, target demographics, and application categories. Geographic coverage spans the Americas, Europe, Middle East, Africa, and AsiaPacific regions, with dedicated country profiles developed for key markets. The research process adhered to rigorous timelines, enabling timely reflection of policy changes and consumer sentiment shifts through mid2025.

Synthesizing Key Insights and Future Directions to Inform DecisionMakers on Strategic Opportunities in the Vascular Health Supplement Sector

In synthesizing the critical insights from this executive summary, it becomes evident that the vascular health supplement sector is at an inflection point driven by consumer demand, scientific innovation, and regulatory evolution. Stakeholders who embrace advanced formulation research, robust compliance frameworks, and digital engagement strategies will be best positioned to capture emerging opportunities.

The interplay between escalating trade costs and strategic supply chain realignment underscores the importance of resilience planning. Companies that diversify sourcing networks and reinforce partnerships with contract manufacturing organizations will be able to maintain operational continuity while navigating tariff landscapes.

Moreover, a deep appreciation of regional nuances-from the regulatory rigor of Europe to the digital commerce boom in North America and the AsiaPacific-will enable tailored market approaches that resonate locally. By aligning segmentation strategies with demographic preferences and usage applications, organizations can refine product positioning and optimize investment priorities.

Ultimately, the insights presented here offer a roadmap for decisionmakers seeking to advance their presence in a rapidly evolving industry. By integrating evidencebased strategies with agility and foresight, stakeholders can forge sustainable growth trajectories and deliver meaningful health outcomes for consumers.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Form
    • Capsule
    • Liquid
    • Powder
    • Softgel
    • Tablet
  • Ingredient Type
    • Coenzyme Q10
    • Hawthorn Extract
    • L-Arginine
    • Niacin
    • Omega-3 Fatty Acid
  • Distribution Channel
    • Health Store
    • Online
      • Brand Website
      • Third Party Platform
    • Pharmacy
      • Chain Pharmacy
      • Independent Pharmacy
    • Supermarket Hypermarket
  • Target Audience
    • Adults Over 45
    • Adults Under 45
  • Application
    • Preventive
      • Cardiovascular Health
      • General Wellbeing
    • Therapeutic
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Herbalife Nutrition Ltd.
  • Amway Corp.
  • Nature's Bounty Co.
  • GNC Holdings, LLC
  • Reckitt Benckiser Group Plc
  • Bayer AG
  • Pharmavite LLC
  • NOW Health Group, Inc.
  • USANA Health Sciences, Inc.
  • Glanbia Plc

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising consumer preference for natural nitric oxide boosters derived from beetroot and citrulline
5.2. Integration of digital health monitoring features in vascular supplement regimen for personalized insights
5.3. Increased investment in clinical trials validating omega-3 fatty acids impact on endothelial function
5.4. Surge in demand for combination formulas pairing L-arginine with antioxidants for enhanced absorption
5.5. Emergence of plant-based flavonoid complexes targeting microvascular circulation support
5.6. Adoption of sustainable packaging innovations in vascular supplement product lines to attract eco-conscious buyers
5.7. Development of patented time-release capsule technology to optimize supplement bioavailability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vascular Health Supplements Market, by Form
8.1. Introduction
8.2. Capsule
8.3. Liquid
8.4. Powder
8.5. Softgel
8.6. Tablet
9. Vascular Health Supplements Market, by Ingredient Type
9.1. Introduction
9.2. Coenzyme Q10
9.3. Hawthorn Extract
9.4. L-Arginine
9.5. Niacin
9.6. Omega-3 Fatty Acid
10. Vascular Health Supplements Market, by Distribution Channel
10.1. Introduction
10.2. Health Store
10.3. Online
10.3.1. Brand Website
10.3.2. Third Party Platform
10.4. Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
10.5. Supermarket Hypermarket
11. Vascular Health Supplements Market, by Target Audience
11.1. Introduction
11.2. Adults Over 45
11.3. Adults Under 45
12. Vascular Health Supplements Market, by Application
12.1. Introduction
12.2. Preventive
12.2.1. Cardiovascular Health
12.2.2. General Wellbeing
12.3. Therapeutic
13. Americas Vascular Health Supplements Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Vascular Health Supplements Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Vascular Health Supplements Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Herbalife Nutrition Ltd.
16.3.2. Amway Corp.
16.3.3. Nature's Bounty Co.
16.3.4. GNC Holdings, LLC
16.3.5. Reckitt Benckiser Group Plc
16.3.6. Bayer AG
16.3.7. Pharmavite LLC
16.3.8. NOW Health Group, Inc.
16.3.9. USANA Health Sciences, Inc.
16.3.10. Glanbia Plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. VASCULAR HEALTH SUPPLEMENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VASCULAR HEALTH SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VASCULAR HEALTH SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VASCULAR HEALTH SUPPLEMENTS MARKET: RESEARCHAI
FIGURE 26. VASCULAR HEALTH SUPPLEMENTS MARKET: RESEARCHSTATISTICS
FIGURE 27. VASCULAR HEALTH SUPPLEMENTS MARKET: RESEARCHCONTACTS
FIGURE 28. VASCULAR HEALTH SUPPLEMENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VASCULAR HEALTH SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY SOFTGEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY SOFTGEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COENZYME Q10, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COENZYME Q10, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY HAWTHORN EXTRACT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY HAWTHORN EXTRACT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY L-ARGININE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY L-ARGININE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY NIACIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY NIACIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY OMEGA-3 FATTY ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY OMEGA-3 FATTY ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY HEALTH STORE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY HEALTH STORE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY THIRD PARTY PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY THIRD PARTY PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ADULTS OVER 45, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ADULTS OVER 45, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ADULTS UNDER 45, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ADULTS UNDER 45, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY GENERAL WELLBEING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY GENERAL WELLBEING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 110. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 111. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 116. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 117. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 118. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 119. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 120. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 121. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 124. CANADA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 126. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 127. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 207. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 208. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 209. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 224. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 225. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 255. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 256. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 257. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 262. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 263. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 266. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 267. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 270. ITALY VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 271. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 272. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 273. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 282. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 283. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 286. SPAIN VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY TARGET AUDIENCE, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA VASCULAR HEALTH SUPPLEMENTS MARKET SIZE, BY PREVENTIVE, 20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vascular Health Supplements market report include:
  • Herbalife Nutrition Ltd.
  • Amway Corp.
  • Nature's Bounty Co.
  • GNC Holdings, LLC
  • Reckitt Benckiser Group Plc
  • Bayer AG
  • Pharmavite LLC
  • NOW Health Group, Inc.
  • USANA Health Sciences, Inc.
  • Glanbia Plc